Australia markets close in 2 hours 14 minutes

Zealand Pharma A/S (ZEAL.CO)

Copenhagen - Copenhagen Real-time price. Currency in DKK
Add to watchlist
224.40+3.20 (+1.45%)
At close: 04:59PM CET
Full screen
Previous close221.20
Open222.60
Bid224.40 x 0
Ask224.20 x 0
Day's range220.20 - 225.80
52-week range69.55 - 228.00
Volume66,068
Avg. volume173,692
Market cap11.508B
Beta (5Y monthly)0.97
PE ratio (TTM)N/A
EPS (TTM)-23.13
Earnings date08 Mar 2023 - 13 Mar 2023
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est243.75
  • GlobeNewswire

    Total number of shares and voting rights in Zealand Pharma at December 30, 2022

    Company announcement – No. 58 / 2022 Total number of shares and voting rights in Zealand Pharma at December 30, 2022 Copenhagen, Denmark and Boston, MA, U.S. December 30, 2022 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, in accordance with section 32 of the Danish Capital Markets Act, announces the total number of shares and voting rights in the Compa

  • GlobeNewswire

    Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants

    Company announcement – No. 57 / 2022 Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants Copenhagen, Denmark and Boston, MA, U.S. December 8, 2022 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, has increased its share capital by a nominal amount of DKK 64,919 divided into 64,919 new shares with a nominal value of

  • GlobeNewswire

    Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

    Company announcement – No. 56/ 2022 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenhagen, Denmark and Boston, MA, U.S. December 2, 2022 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, has received information on transactions in Zealand's share